electroCore (NASDAQ:ECOR) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
electroCore (NASDAQ:ECOR) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
electroCore (NASDAQ:ECOR) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
electroCore (NASDAQ:ECOR) had its price target lowered by analysts at HC Wainwright from $25.00 to $18.00. They now have a "buy" rating on the stock.
Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)